SecBot SecBot
SECBOTREPLAY Home › Report › RMD

RMD · ResMed insiders sold $1.8M in shares over a 7-day period, led by CEO…

RESMED INC · CLUSTER filed Mar 31, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Mar 31, 2026 at 20:00 ET

ResMed insiders sold $1.8M in shares over a 7-day period, led by CEO Michael Farrell's $1.13M open-market sale following the exercise of derivative securities. The total value represents 0.005% of ResMed's $33.6B market cap, indicating routine, non-material activity.

  • CEO Michael Farrell sold 4,991 shares for $1.13M in an open-market transaction on 2026-04-07.
  • Farrell also exercised derivative securities totaling 9,982 shares (one tranche at $0, one at $146.34), a non-cash event.
  • Director Peter Farrell sold $450K and CFO Brett Sandercock sold $224K, both on 2026-04-01.
  • Total insider selling: $1.8M over 7 days, all by insiders with pre-arranged 10b5-1 plans likely.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access